149 related articles for article (PubMed ID: 1498067)
1. Epirubicin/dacarbazine rapidly alternated with ifosfamide in the treatment of metastatic soft tissue sarcomas.
Bokemeyer C; Harstrick A; Schmoll HJ; Köhne-Wömpner CH; Schöffski P; Poliwoda H
Ann Oncol; 1992 Jun; 3(6):487-8. PubMed ID: 1498067
[TBL] [Abstract][Full Text] [Related]
2. A pilot study of rapidly alternating epirubicin/dacarbazine and ifosfamide as first-line therapy for metastatic soft-tissue sarcoma in adults.
Harstrick A; Bokemeyer C; Schmoll HJ; Köhne-Wömpner CH; Knipp H; Schöffski P; Anagnou J; Wipperman B; Neumann S; Poliwoda H
Cancer Chemother Pharmacol; 1993; 31 Suppl 2():S217-21. PubMed ID: 8453702
[TBL] [Abstract][Full Text] [Related]
3. A phase II study of dose-intense ifosfamide plus epirubicin with hematopoietic growth factors for the treatment of patients with advanced soft tissue sarcomas; a novel sequential schedule.
Serrone L; Zeuli M; Gamucci T; Nardi M; Cognetti F
Cancer Chemother Pharmacol; 2001 Mar; 47(3):206-10. PubMed ID: 11320663
[TBL] [Abstract][Full Text] [Related]
4. Ifosfamide plus epirubicin at escalating doses in the treatment of locally advanced and/or metastatic sarcomas.
Toma S; Palumbo R; Canavese G; Albanese E; Cantoni E; Barisone A; Reggiardo G; Rosso R; Santi L
Cancer Chemother Pharmacol; 1993; 31 Suppl 2():S222-7. PubMed ID: 8453703
[TBL] [Abstract][Full Text] [Related]
5. Epirubicin plus ifosfamide and dacarbazine (EID) in advanced soft tissue sarcomas.
Casali P; Pastorino U; Zucchinelli P; Devizzi L; Azzarelli A; Quagliuolo V; Bignami P; Santoro A; Bonadonna G
Ann Oncol; 1992 Apr; 3 Suppl 2():S125-6. PubMed ID: 1622854
[No Abstract] [Full Text] [Related]
6. Treatment results obtained in metastatic soft-tissue sarcoma with a combination of doxorubicin and dacarbazine or doxorubicin and ifosfamide.
Weh HJ; Agarwal K; Zornig C; Schwarz R; Dietel M; Hossfeld DK
Cancer Chemother Pharmacol; 1993; 31 Suppl 2():S189-93. PubMed ID: 8453696
[TBL] [Abstract][Full Text] [Related]
7. Epirubicin and ifosfamide in advanced soft tissue sarcoma: a phase II study.
Chevallier B; Leyvraz S; Olivier JP; Fargeot P; Facchini T; Vo Van ML
Cancer Invest; 1993; 11(2):135-9. PubMed ID: 8462014
[TBL] [Abstract][Full Text] [Related]
8. Phase II evaluation of doxorubicin, ifosfamide, and dacarbazine plus amphotericin B in the treatment of metastatic soft tissue sarcomas. A pilot study.
González-Manzano R; Vieitez JM; Tangco E; Fernandez de Alava E; Herranz P; Garcia-Foncillas J
Am J Clin Oncol; 1993 Aug; 16(4):332-7. PubMed ID: 8328412
[TBL] [Abstract][Full Text] [Related]
9. Epirubicin and DTIC (EDIC) for advanced soft-tissue sarcomas.
Lopez M; Carpano S; Di Lauro L; Vici P; Conti EM
Oncology; 1991; 48(3):230-3. PubMed ID: 2023703
[TBL] [Abstract][Full Text] [Related]
10. Combination chemotherapy with doxorubicin, dacarbazine, and ifosfamide in advanced adult soft tissue sarcoma. Canadian Sarcoma Group--National Cancer Institute of Canada Clinical Trials Group.
Bramwell V; Quirt I; Warr D; Verma S; Young V; Knowling M; Eisenhauer E
J Natl Cancer Inst; 1989 Oct; 81(19):1496-9. PubMed ID: 2778839
[TBL] [Abstract][Full Text] [Related]
11. Chemotherapy of advanced sarcomas of bone and soft tissue.
Antman KH
Semin Oncol; 1992 Dec; 19(6 Suppl 12):13-20. PubMed ID: 1485169
[TBL] [Abstract][Full Text] [Related]
12. Accelerated epirubicin-ifosfamide-dacarbazine regimen in patients with adult soft tissue sarcomas.
Michelotti A; Romanini A; Giannessi P; Bengala C; Conte P
Am J Clin Oncol; 1996 Feb; 19(1):78-81. PubMed ID: 8554042
[TBL] [Abstract][Full Text] [Related]
13. Response to mesna, doxorubicin, ifosfamide, and dacarbazine in 108 patients with metastatic or unresectable sarcoma and no prior chemotherapy.
Elias A; Ryan L; Sulkes A; Collins J; Aisner J; Antman KH
J Clin Oncol; 1989 Sep; 7(9):1208-16. PubMed ID: 2504890
[TBL] [Abstract][Full Text] [Related]
14. Ifosfamide and epirubicin combination in untreated sarcomas: two treatment schedules.
Serrone L; Zeuli M; Papaldo P; Nardoni C; Pacetti U; Cognetti F
Onkologie; 2001 Oct; 24(5):465-8. PubMed ID: 11694773
[TBL] [Abstract][Full Text] [Related]
15. An intergroup phase III randomized study of doxorubicin and dacarbazine with or without ifosfamide and mesna in advanced soft tissue and bone sarcomas.
Antman K; Crowley J; Balcerzak SP; Rivkin SE; Weiss GR; Elias A; Natale RB; Cooper RM; Barlogie B; Trump DL
J Clin Oncol; 1993 Jul; 11(7):1276-85. PubMed ID: 8315425
[TBL] [Abstract][Full Text] [Related]
16. Epirubicin and ifosfamide in advanced soft tissue sarcomas.
Frustaci S; Foladore S; Buonadonna A; De Paoli A; Crivellari D; Carbone A; Sorio R; Morassut S; Monfardini S
Ann Oncol; 1993 Sep; 4(8):669-72. PubMed ID: 8240997
[TBL] [Abstract][Full Text] [Related]
17. Sequential dose-dense doxorubicin and ifosfamide for advanced soft tissue sarcomas: a Phase II trial by the Spanish Group for Research on Sarcomas (GEIS).
Maurel J; Fra J; López-Pousa A; García del Muro X; Balañá C; Casado A; Martín J; Martínez-Trufero J; de las Peñas R; Buesa JM;
Cancer; 2004 Apr; 100(7):1498-506. PubMed ID: 15042685
[TBL] [Abstract][Full Text] [Related]
18. Phase II trial of ifosfamide and cisplatin in the treatment of metastatic sarcomas: a Southwest Oncology Group study.
Budd GT; Metch B; Weiss SA; Weick JK; Fabian C; Stephens RL; Balcerzak SP
Cancer Chemother Pharmacol; 1993; 31 Suppl 2():S213-6. PubMed ID: 8453701
[TBL] [Abstract][Full Text] [Related]
19. Efficacy of lenograstim on hematologic tolerance to MAID chemotherapy in patients with advanced soft tissue sarcoma and consequences on treatment dose-intensity.
Bui BN; Chevallier B; Chevreau C; Krakowski I; Peny AM; Thyss A; Maugard-Louboutin C; Cupissol D; Fargeot P; Bonichon F
J Clin Oncol; 1995 Oct; 13(10):2629-36. PubMed ID: 7595717
[TBL] [Abstract][Full Text] [Related]
20. [Preliminary result of advanced soft tissue sarcoma treated by MAID regimen].
Huang YH; Wen XP; Hu L
Ai Zheng; 2002 Aug; 21(8):907-9. PubMed ID: 12478905
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
